These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 34065187)

  • 21. Effect of Probiotic Supplementation on Gut Microbiota in Patients with Major Depressive Disorders: A Systematic Review.
    Ng QX; Lim YL; Yaow CYL; Ng WK; Thumboo J; Liew TM
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of probiotics on depressive symptoms: A meta-analysis of human studies.
    Goh KK; Liu YW; Kuo PH; Chung YE; Lu ML; Chen CH
    Psychiatry Res; 2019 Dec; 282():112568. PubMed ID: 31563280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
    Kopschina Feltes P; Doorduin J; Klein HC; Juárez-Orozco LE; Dierckx RA; Moriguchi-Jeckel CM; de Vries EF
    J Psychopharmacol; 2017 Sep; 31(9):1149-1165. PubMed ID: 28653857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota-brain axis in depression: The role of neuroinflammation.
    Carlessi AS; Borba LA; Zugno AI; Quevedo J; Réus GZ
    Eur J Neurosci; 2021 Jan; 53(1):222-235. PubMed ID: 31785168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms.
    Chahwan B; Kwan S; Isik A; van Hemert S; Burke C; Roberts L
    J Affect Disord; 2019 Jun; 253():317-326. PubMed ID: 31078831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Probiotics and Prebiotics on Mental Disorders: A Review on Depression, Anxiety, Alzheimer, and Autism Spectrum Disorders.
    Ansari F; Pourjafar H; Tabrizi A; Homayouni A
    Curr Pharm Biotechnol; 2020; 21(7):555-565. PubMed ID: 31914909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers.
    Mohammadi AA; Jazayeri S; Khosravi-Darani K; Solati Z; Mohammadpour N; Asemi Z; Adab Z; Djalali M; Tehrani-Doost M; Hosseini M; Eghtesadi S
    Nutr Neurosci; 2016 Nov; 19(9):387-395. PubMed ID: 25879690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated review of research on the gut microbiota and their relation to depression in animals and human beings.
    Yang Z; Li J; Gui X; Shi X; Bao Z; Han H; Li MD
    Mol Psychiatry; 2020 Nov; 25(11):2759-2772. PubMed ID: 32332994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness.
    Macedo D; Filho AJMC; Soares de Sousa CN; Quevedo J; Barichello T; Júnior HVN; Freitas de Lucena D
    J Affect Disord; 2017 Jan; 208():22-32. PubMed ID: 27744123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimmunology of depression.
    Sarno E; Moeser AJ; Robison AJ
    Adv Pharmacol; 2021; 91():259-292. PubMed ID: 34099111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychobiotics: a novel class of psychotropic.
    Dinan TG; Stanton C; Cryan JF
    Biol Psychiatry; 2013 Nov; 74(10):720-6. PubMed ID: 23759244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.
    Bastiaanssen TFS; Cussotto S; Claesson MJ; Clarke G; Dinan TG; Cryan JF
    Harv Rev Psychiatry; 2020; 28(1):26-39. PubMed ID: 31913980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An initial exploration of hair cortisol responses to antidepressants in unmedicated patients with depression.
    Song X; Cui W; Peng Z; Zhao L; Yu X; Li T; Cui L; Ma X
    J Int Med Res; 2020 Mar; 48(3):300060519889431. PubMed ID: 31849246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
    Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
    J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The brain-gut axis: a target for treating stress-related disorders.
    Scott LV; Clarke G; Dinan TG
    Mod Trends Pharmacopsychiatry; 2013; 28():90-9. PubMed ID: 25224893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermingling of gut microbiota with brain: Exploring the role of probiotics in battle against depressive disorders.
    Tyagi P; Tasleem M; Prakash S; Chouhan G
    Food Res Int; 2020 Nov; 137():109489. PubMed ID: 33233143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of probiotic interventions on depressive symptoms: A narrative review evaluating systematic reviews.
    Nadeem I; Rahman MZ; Ad-Dab'bagh Y; Akhtar M
    Psychiatry Clin Neurosci; 2019 Apr; 73(4):154-162. PubMed ID: 30499231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PROVIT: Supplementary Probiotic Treatment and Vitamin B7 in Depression-A Randomized Controlled Trial.
    Reininghaus EZ; Platzer M; Kohlhammer-Dohr A; Hamm C; Mörkl S; Bengesser SA; Fellendorf FT; Lahousen-Luxenberger T; Leitner-Afschar B; Schöggl H; Amberger-Otti D; Wurm W; Queissner R; Birner A; Falzberger VS; Painold A; Fitz W; Wagner-Skacel J; Brunnmayr M; Rieger A; Maget A; Unterweger R; Schwalsberger K; Reininghaus B; Lenger M; Bastiaanssen TFS; Dalkner N
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33171595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.